These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 39243894)
1. Treatment efficacy of cidofovir and brincidofovir against clade II Monkeypox virus isolates. Prévost J; Sloan A; Deschambault Y; Tailor N; Tierney K; Azaransky K; Kammanadiminti S; Barker D; Kodihalli S; Safronetz D Antiviral Res; 2024 Nov; 231():105995. PubMed ID: 39243894 [TBL] [Abstract][Full Text] [Related]
2. Exploring the Potential Treatment for Mpox. Kevin K; Sinto R; Nainggolan L; Pasaribu A; Shakinah S; Lie KC Acta Med Indones; 2024 Jul; 56(3):400-408. PubMed ID: 39463117 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model. Hutson CL; Kondas AV; Mauldin MR; Doty JB; Grossi IM; Morgan CN; Ostergaard SD; Hughes CM; Nakazawa Y; Kling C; Martin BE; Ellison JA; Carroll DS; Gallardo-Romero NF; Olson VA mSphere; 2021 Feb; 6(1):. PubMed ID: 33536322 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic agents for the treatment of human mpox. Braddick M; Singh KP Curr Opin Infect Dis; 2024 Dec; 37(6):518-525. PubMed ID: 39382085 [TBL] [Abstract][Full Text] [Related]
5. Antivirals With Activity Against Mpox: A Clinically Oriented Review. Siegrist EA; Sassine J Clin Infect Dis; 2023 Jan; 76(1):155-164. PubMed ID: 35904001 [TBL] [Abstract][Full Text] [Related]
6. Treatment and Vaccination for Smallpox and Monkeypox. Saalbach KP Adv Exp Med Biol; 2024; 1451():301-316. PubMed ID: 38801586 [TBL] [Abstract][Full Text] [Related]
7. Identification of Chiem K; Nogales A; Lorenzo M; Morales Vasquez D; Xiang Y; Gupta YK; Blasco R; de la Torre JC; Martínez-Sobrido L Microbiol Spectr; 2023 Aug; 11(4):e0474522. PubMed ID: 37278625 [TBL] [Abstract][Full Text] [Related]
8. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses. Smee DF; Sidwell RW; Kefauver D; Bray M; Huggins JW Antimicrob Agents Chemother; 2002 May; 46(5):1329-35. PubMed ID: 11959564 [TBL] [Abstract][Full Text] [Related]
9. Potential therapeutic targets for Mpox: the evidence to date. Byrareddy SN; Sharma K; Sachdev S; Reddy AS; Acharya A; Klaustermeier KM; Lorson CL; Singh K Expert Opin Ther Targets; 2023; 27(6):419-431. PubMed ID: 37368464 [TBL] [Abstract][Full Text] [Related]
10. In vitro efficacy of brincidofovir against variola virus. Olson VA; Smith SK; Foster S; Li Y; Lanier ER; Gates I; Trost LC; Damon IK Antimicrob Agents Chemother; 2014 Sep; 58(9):5570-1. PubMed ID: 24957837 [TBL] [Abstract][Full Text] [Related]
11. Clinical considerations on monkeypox antiviral medications: An overview. Pourkarim F; Entezari-Maleki T Pharmacol Res Perspect; 2024 Feb; 12(1):e01164. PubMed ID: 38149674 [TBL] [Abstract][Full Text] [Related]
12. Structural basis of human mpox viral DNA replication inhibition by brincidofovir and cidofovir. Xu Y; Wu Y; Wu X; Zhang Y; Yang Y; Li D; Yang B; Gao K; Zhang Z; Dong C Int J Biol Macromol; 2024 Jun; 270(Pt 2):132231. PubMed ID: 38735603 [TBL] [Abstract][Full Text] [Related]
14. Molecular Virology of Orthopoxviruses with Special Reference to Monkeypox Virus. Rohaim MA; Naggar RFE; Atasoy MO; Munir M Adv Exp Med Biol; 2024; 1451():111-124. PubMed ID: 38801574 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf. De Clercq E; Jiang Y; Li G Travel Med Infect Dis; 2023; 52():102528. PubMed ID: 36539022 [TBL] [Abstract][Full Text] [Related]
16. Mpox Virus and its ocular surface manifestations. Chakravarty N; Hemani D; Paravastu R; Ahmad Z; Palani SN; Arumugaswami V; Kumar A Ocul Surf; 2024 Jul; 34():108-121. PubMed ID: 38972544 [TBL] [Abstract][Full Text] [Related]
17. A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox. Hung YP; Lee CC; Lee JC; Chiu CW; Hsueh PR; Ko WC J Microbiol Immunol Infect; 2022 Oct; 55(5):795-802. PubMed ID: 36115792 [TBL] [Abstract][Full Text] [Related]
18. Update on monkeypox virus infection: Focusing current treatment and prevention approaches. Dhapola R; Kumari S; Sharma P; KumarKushawaha P; HariKrishnaReddy D Fundam Clin Pharmacol; 2024 Jun; 38(3):465-478. PubMed ID: 38226405 [TBL] [Abstract][Full Text] [Related]
19. Repurposing of the antibiotic nitroxoline for the treatment of mpox. Bojkova D; Zöller N; Tietgen M; Steinhorst K; Bechtel M; Rothenburger T; Kandler JD; Schneider J; Corman VM; Ciesek S; Rabenau HF; Wass MN; Kippenberger S; Göttig S; Michaelis M; Cinatl J J Med Virol; 2023 Mar; 95(3):e28652. PubMed ID: 36897017 [TBL] [Abstract][Full Text] [Related]
20. Identification of IMP Dehydrogenase as a Potential Target for Anti-Mpox Virus Agents. Hishiki T; Morita T; Akazawa D; Ohashi H; Park ES; Kataoka M; Mifune J; Shionoya K; Tsuchimoto K; Ojima S; Azam AH; Nakajima S; Kawahara M; Yoshikawa T; Shimojima M; Kiga K; Maeda K; Suzuki T; Ebihara H; Takahashi Y; Watashi K Microbiol Spectr; 2023 Aug; 11(4):e0056623. PubMed ID: 37409948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]